Released : January 23, 2018 13:32 RNS Number : 6888C MaxCyte, Inc. 23 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 23 January 2018: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 18,293 new shares of common
Released : January 22, 2018 07:00 RNS Number : 4641C MaxCyte, Inc. 22 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Trading Update Gaithersburg, Maryland - 22 January 2018: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration of the discovery,
Released : January 12, 2018 17:13 RNS Number : 7976B MaxCyte, Inc. 12 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 12 January 2018: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 18,293 new shares of common
Gaithersburg, Maryland – January 2, 2018 : MaxCyte announced today that Debra K. Bowes, Executive Vice President, Business and Strategic Development , will present at two life sciences conferences this month: the Biotech Showcase on January 8 at 3:30 p.m.
Released : November 30, 2017 15:26 RNS Number : 0291Y MaxCyte, Inc. 30 November 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 30 November 2017: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 41,121 new shares of common
Released : October 31, 2017 12:47 RNS Number : 1243V MaxCyte, Inc. 31 October 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Result of AGM Maryland, USA - 31 October 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration of the discovery, development,
Released : October 16, 2017 07:00 RNS Number : 6267T MaxCyte, Inc. 16 October 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Declaration of Audit Remuneration Maryland, USA - 16 October 2017: MaxCyte (LSE: MXCT, MXCR), in order to assist investors in considering the resolutions
Released : October 05, 2017 18:32 RNS Number : 8773S MaxCyte, Inc. 05 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Released : October 05, 2017 18:31 RNS Number : 8770S MaxCyte, Inc. 05 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a.
Released : September 28, 2017 17:15 RNS Number : 1589S MaxCyte, Inc. 28 September 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Notification of Annual General Meeting Maryland, USA - 28 September 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration
